Development of preneoplastic and neoplastic lesions of the liver in male rats given 0.025 percent N-2-fluorenyldiacetamide.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000209:etiology* / Q000473:pathology*; D005453:Fluorescence / Q000009:adverse effects*; D006965:Hyperplasia / Q000209:etiology* / Q000473:pathology*; D008106:Liver Cirrhosis, Experimental / Q000209:etiology* / Q000473:pathology*; D008107:Liver Diseases / Q000209:etiology* / Q000473:pathology*; D008113:Liver Neoplasms; D009374:Neoplasms, Experimental; D051381:Rats